CAS RN: 40716-66-3
Nerolidol
Product Availability
Choose a grade to view its available package options.
6 package records6 with current stock2 grade groups
| Batch No. | Package | Availability | Warehouse | Inquiry |
| Batchno.20250309 |
100g |
In stock |
Shanghai, Shenzhen, Tianjin, Wuhan | Inquiry |
| Batchno.20250511 |
1kg |
In stock |
Shanghai | Inquiry |
| Batchno.20250725 |
25g |
In stock |
Shanghai, Chengdu | Inquiry |
| Batchno.20251130 |
500g |
In stock |
Shanghai | Inquiry |
| Batchno.20250506 |
5g |
In stock |
Shanghai, Shenzhen, Tianjin, Chengdu | Inquiry |
| Batch No. | Package | Availability | Warehouse | Inquiry |
| Batchno.20260529 |
5g / 25g / 100g / 500g / 2.5kg |
Confirm by inquiry |
Shanghai, Shandong, Hebei | Inquiry |
-
Product code:
starshine_CAS40716-66-3
-
Purity/Analytical Methods:
>99.0%
GET A QUOTE
40716-66-3 / 3,7,11-trimethyldodeca-1,6,10-trien-3-ol
Standard CAS: 40716-66-3
Multi CAS: Yes
Basic Information
CAS
40716-66-3
Multi CAS
Yes
Molecular Formula
C15H26O
Molecular Weight
222.370000
Exact Mass
222.198365
InChI
InChI=1S/C15H26O/c1-6-15(5,16)12-8-11-14(4)10-7-9-13(2)3/h6,9,11,16H,1,7-8,10,12H2,2-5H3/b14-11+
InChIKey
FQTLCLSUCSAZDY-SDNWHVSQSA-N
Physical Properties
Melting Point
< 25 °C
Boiling Point
114.00 °C. @ 1.00 mm Hg
Physical Description
Solid
State
Solid
Computed Properties
Structural Parameters
Heavy atom count
16
Fraction Csp3
0.6
Rotatable bonds
7
H-bond acceptors
1
H-bond donors
1
Molar refractivity
72.48
TPSA
20.23
LogP / Solubility
WLOGP
4.4
MLOGP
3.87
XLogP3
4.6
Consensus LogP
4.29
Log S (ESOL)
-3.53
Class (ESOL)
Poorly soluble
Log S (Ali)
-4.56
Class (Ali)
Slightly soluble
Log S (SILICOS-IT)
-5.59
Class (SILICOS-IT)
Slightly soluble
ADME
GI absorption
High
BBB permeant
No
P-gp substrate
No
CYP1A2 inhibitor
No
CYP2C19 inhibitor
No
CYP2C9 inhibitor
No
CYP2D6 inhibitor
No
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-0.96
Drug-likeness / Medicinal Chemistry
Lipinski
Yes
Ghose
No
Veber
Yes
Egan
Yes
Muegge
No
Bioavailability score
0.55
Brenk alerts
1
Leadlikeness
No
Synthetic Accessibility
2